Kim Taeg S, Perlman Stanley
Interdisciplinary Program in Immunology, Department of Pediatrics, University of Iowa, Iowa City, IA 52242, USA.
J Immunol. 2003 Aug 15;171(4):2006-13. doi: 10.4049/jimmunol.171.4.2006.
CTL escape mutations have been identified in several chronic infections, including mice infected with mouse hepatitis virus strain JHM. One outstanding question in understanding CTL escape is whether a CD8 T cell response to two or more immunodominant CTL epitopes would prevent CTL escape. Although CTL escape at multiple epitopes seems intuitively unlikely, CTL escape at multiple CD8 T cell epitopes has been documented in some chronically infected individual animals. To resolve this apparent contradiction, we engineered a recombinant variant of JHM that expressed the well-characterized gp33 epitope of lymphocytic choriomeningitis virus, an epitope with high functional avidity. The results show that the presence of a host response to this second epitope protected mice against CTL escape at the immunodominant JHM-specific CD8 T cell epitope, the persistence of infectious virus, and the development of clinical disease.
在包括感染小鼠肝炎病毒JHM株的小鼠在内的几种慢性感染中,已鉴定出CTL逃逸突变。理解CTL逃逸的一个突出问题是,针对两个或更多免疫显性CTL表位的CD8 T细胞反应是否能预防CTL逃逸。虽然多个表位的CTL逃逸直观上似乎不太可能,但在一些慢性感染的个体动物中已记录到多个CD8 T细胞表位的CTL逃逸。为了解决这一明显的矛盾,我们构建了一种JHM重组变体,它表达了特征明确的淋巴细胞性脉络丛脑膜炎病毒gp33表位,这是一个具有高功能亲和力的表位。结果表明,宿主对这第二个表位的反应可保护小鼠免受免疫显性JHM特异性CD8 T细胞表位的CTL逃逸、传染性病毒的持续存在以及临床疾病的发展。